Carelon ResearchWilmington, Delaware, United States
Disclosure information not submitted.
4C-06 - Evolution of Drug Initiation Patterns and Clinical Characteristics of New Users of Dapagliflozin in the United States up to 10 Years After Approval to Treat Type 2 Diabetes
Monday, August 25, 20255:30 PM - 5:45 PM ET
5E-04 - Comparative safety of glucagon-like peptide 1 receptor agonists (GLP-1-RAs) in chronic weight management patients without diabetes: a real-world data study
Tuesday, August 26, 20259:15 AM - 9:30 AM ET
6E-01 - Calculating number needed to treat (NNT) for studies using real world data with variable follow-up times: Kaplan-Meier versus rate-based approach
Tuesday, August 26, 20251:30 PM - 1:45 PM ET
